ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SYRS Syros Pharmaceuticals Inc

5.20
-0.24 (-4.41%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Syros Pharmaceuticals Inc SYRS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.24 -4.41% 5.20 09:37:27
Open Price Low Price High Price Close Price Previous Close
5.53 5.185 5.64 5.20 5.44
more quote information »

Recent News

Date Time Source Heading
09/4/202421:00BWSyros Receives Fast Track Designation from the FDA for..
03/4/202407:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
27/3/202422:30BWSyros Reports Fourth Quarter and Full Year 2023 Financial..
27/3/202421:57IHMARKETNEWSU.S. Stock Index Futures Point to a Rebound, Oil See..
25/3/202422:00BWSyros Announces Completion of Enrollment of 190 Patients..
20/3/202422:00BWSyros to Report Fourth Quarter and Full Year 2023 Financial..
27/2/202423:00BWSyros to Participate in TD Cowen 44th Annual Health Care..
15/2/202412:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202412:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202411:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202410:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202423:06EDGAR2Form 8-K - Current report
08/1/202423:00BWSyros Highlights Anticipated 2024 Milestones to Deliver on..
03/1/202408:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/12/202309:19EDGAR2Form SC 13D/A - General statement of acquisition of..
20/12/202308:59EDGAR2Form 8-K - Current report
20/12/202308:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202323:27BWSyros Announces Pricing of $45.0 million Underwritten..
15/12/202308:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202308:12EDGAR2Form 144 - Report of proposed sale of securities
09/12/202308:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202308:00EDGAR2Form 144 - Report of proposed sale of securities
06/12/202323:05EDGAR2Form 8-K - Current report
06/12/202323:00BWSyros Announces Encouraging Initial Data from Randomized..
06/12/202309:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202323:30BWSyros to Participate in Upcoming Investor Conferences
14/11/202323:30BWSyros Reports Third Quarter 2023 Financial Results and..
14/11/202322:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:30BWSyros to Report Third Quarter 2023 Financial Results on..
03/11/202307:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202307:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202307:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202307:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202307:15EDGAR2Form SC 13D - General statement of acquisition of beneficial..
02/10/202323:49EDGAR2Form 8-K - Current report
02/10/202323:45BWSyros Announces Planned CEO Leadership Transition and..
08/9/202306:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
12/8/202306:30EDGAR2Form 8-K - Current report
08/8/202321:30BWSyros Reports Second Quarter 2023 Financial Results and..
08/8/202320:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202306:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
03/8/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202321:30BWSyros to Report Second Quarter 2023 Financial Results on..
01/8/202306:12EDGAR2Form 144 - Report of proposed sale of securities
22/7/202306:36EDGAR2Form 8-K - Current report
19/7/202310:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202306:00EDGAR2Form 144 - Report of proposed sale of securities
06/7/202306:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
08/6/202321:30BWSyros to Present at Sidoti June 2023 Virtual Small-Cap..
02/6/202306:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..

Your Recent History

Delayed Upgrade Clock